 | • レポートコード：MRC2-11QY12177 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は遺伝性がん検査のグローバル市場について調査・分析したレポートです。種類別（RNA検査、DNA検査）市場規模、用途別（乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他がん）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別遺伝性がん検査の競争状況、市場シェア ・世界の遺伝性がん検査市場：種類別市場規模 2015年-2020年（RNA検査、DNA検査） ・世界の遺伝性がん検査市場：種類別市場規模予測 2021年-2026年（RNA検査、DNA検査） ・世界の遺伝性がん検査市場：用途別市場規模 2015年-2020年（乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他がん） ・世界の遺伝性がん検査市場：用途別市場規模予測 2021年-2026年（乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他がん） ・北米の遺伝性がん検査市場分析：米国、カナダ ・ヨーロッパの遺伝性がん検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの遺伝性がん検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の遺伝性がん検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの遺伝性がん検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Ambry Genetics (Konica Minota)、Asper Biogene、Natera、Caris Life Sciences、BioReference Laboratories (GeneDx)、LabSolutions、Progenity，Inc、ARUP Laboratories、NeoGenomics、Blueprint Genetics、CellMax Life、Fulgent Genetics、Myriad Genetics、Myogenes、LabCorp、Quest Diagnostics、Pathway Genomics、Strand Life Sciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation from ancestry. In DNA sequencing, entire DNA or genome of an individual is analyzed. It is useful for testing many genetic mutations at a time.
Market Analysis and Insights: Global Hereditary Cancer Testing Market
The global Hereditary Cancer Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hereditary Cancer Testing Scope and Market Size
Hereditary Cancer Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity，Inc
ARUP Laboratories
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Myriad Genetics
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics
Strand Life Sciences
Market segment by Type, the product can be split into
RNA Testing
DNA Testing
Market segment by Application, split into
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue
1.4 Market by Type
1.4.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 RNA Testing
1.4.3 DNA Testing
1.5 Market by Application
1.5.1 Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026
1.5.2 Breast Cancer
1.5.3 Gastrointestinal Cancer
1.5.4 Prostate Cancer
1.5.5 Respiratory/Lung Cancer
1.5.6 Other Cancers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Cancer Testing Market Perspective (2015-2026)
2.2 Global Hereditary Cancer Testing Growth Trends by Regions
2.2.1 Hereditary Cancer Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hereditary Cancer Testing Historic Market Share by Regions (2015-2020)
2.2.3 Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hereditary Cancer Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Hereditary Cancer Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Cancer Testing Players by Market Size
3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2015-2020)
3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hereditary Cancer Testing Market Concentration Ratio
3.2.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2019
3.3 Hereditary Cancer Testing Key Players Head office and Area Served
3.4 Key Players Hereditary Cancer Testing Product Solution and Service
3.5 Date of Enter into Hereditary Cancer Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2015-2020)
4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hereditary Cancer Testing Market Size by Application (2015-2020)
5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hereditary Cancer Testing Market Size (2015-2020)
6.2 Hereditary Cancer Testing Key Players in North America (2019-2020)
6.3 North America Hereditary Cancer Testing Market Size by Type (2015-2020)
6.4 North America Hereditary Cancer Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hereditary Cancer Testing Market Size (2015-2020)
7.2 Hereditary Cancer Testing Key Players in Europe (2019-2020)
7.3 Europe Hereditary Cancer Testing Market Size by Type (2015-2020)
7.4 Europe Hereditary Cancer Testing Market Size by Application (2015-2020)
8 China
8.1 China Hereditary Cancer Testing Market Size (2015-2020)
8.2 Hereditary Cancer Testing Key Players in China (2019-2020)
8.3 China Hereditary Cancer Testing Market Size by Type (2015-2020)
8.4 China Hereditary Cancer Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hereditary Cancer Testing Market Size (2015-2020)
9.2 Hereditary Cancer Testing Key Players in Japan (2019-2020)
9.3 Japan Hereditary Cancer Testing Market Size by Type (2015-2020)
9.4 Japan Hereditary Cancer Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hereditary Cancer Testing Market Size (2015-2020)
10.2 Hereditary Cancer Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020)
11 India
11.1 India Hereditary Cancer Testing Market Size (2015-2020)
11.2 Hereditary Cancer Testing Key Players in India (2019-2020)
11.3 India Hereditary Cancer Testing Market Size by Type (2015-2020)
11.4 India Hereditary Cancer Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hereditary Cancer Testing Market Size (2015-2020)
12.2 Hereditary Cancer Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Hereditary Cancer Testing Market Size by Type (2015-2020)
12.4 Central & South America Hereditary Cancer Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Ambry Genetics (Konica Minota)
13.1.1 Ambry Genetics (Konica Minota) Company Details
13.1.2 Ambry Genetics (Konica Minota) Business Overview
13.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
13.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020))
13.1.5 Ambry Genetics (Konica Minota) Recent Development
13.2 Asper Biogene
13.2.1 Asper Biogene Company Details
13.2.2 Asper Biogene Business Overview
13.2.3 Asper Biogene Hereditary Cancer Testing Introduction
13.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020)
13.2.5 Asper Biogene Recent Development
13.3 Natera
13.3.1 Natera Company Details
13.3.2 Natera Business Overview
13.3.3 Natera Hereditary Cancer Testing Introduction
13.3.4 Natera Revenue in Hereditary Cancer Testing Business (2015-2020)
13.3.5 Natera Recent Development
13.4 Caris Life Sciences
13.4.1 Caris Life Sciences Company Details
13.4.2 Caris Life Sciences Business Overview
13.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
13.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020)
13.4.5 Caris Life Sciences Recent Development
13.5 BioReference Laboratories (GeneDx)
13.5.1 BioReference Laboratories (GeneDx) Company Details
13.5.2 BioReference Laboratories (GeneDx) Business Overview
13.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
13.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020)
13.5.5 BioReference Laboratories (GeneDx) Recent Development
13.6 LabSolutions
13.6.1 LabSolutions Company Details
13.6.2 LabSolutions Business Overview
13.6.3 LabSolutions Hereditary Cancer Testing Introduction
13.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020)
13.6.5 LabSolutions Recent Development
13.7 Progenity，Inc
13.7.1 Progenity，Inc Company Details
13.7.2 Progenity，Inc Business Overview
13.7.3 Progenity，Inc Hereditary Cancer Testing Introduction
13.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2015-2020)
13.7.5 Progenity，Inc Recent Development
13.8 ARUP Laboratories
13.8.1 ARUP Laboratories Company Details
13.8.2 ARUP Laboratories Business Overview
13.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
13.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020)
13.8.5 ARUP Laboratories Recent Development
13.9 NeoGenomics
13.9.1 NeoGenomics Company Details
13.9.2 NeoGenomics Business Overview
13.9.3 NeoGenomics Hereditary Cancer Testing Introduction
13.9.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020)
13.9.5 NeoGenomics Recent Development
13.10 Blueprint Genetics
13.10.1 Blueprint Genetics Company Details
13.10.2 Blueprint Genetics Business Overview
13.10.3 Blueprint Genetics Hereditary Cancer Testing Introduction
13.10.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
13.10.5 Blueprint Genetics Recent Development
13.11 CellMax Life
10.11.1 CellMax Life Company Details
10.11.2 CellMax Life Business Overview
10.11.3 CellMax Life Hereditary Cancer Testing Introduction
10.11.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020)
10.11.5 CellMax Life Recent Development
13.12 Fulgent Genetics
10.12.1 Fulgent Genetics Company Details
10.12.2 Fulgent Genetics Business Overview
10.12.3 Fulgent Genetics Hereditary Cancer Testing Introduction
10.12.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.12.5 Fulgent Genetics Recent Development
13.13 Myriad Genetics
10.13.1 Myriad Genetics Company Details
10.13.2 Myriad Genetics Business Overview
10.13.3 Myriad Genetics Hereditary Cancer Testing Introduction
10.13.4 Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.13.5 Myriad Genetics Recent Development
13.14 Myogenes
10.14.1 Myogenes Company Details
10.14.2 Myogenes Business Overview
10.14.3 Myogenes Hereditary Cancer Testing Introduction
10.14.4 Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020)
10.14.5 Myogenes Recent Development
13.15 LabCorp
10.15.1 LabCorp Company Details
10.15.2 LabCorp Business Overview
10.15.3 LabCorp Hereditary Cancer Testing Introduction
10.15.4 LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020)
10.15.5 LabCorp Recent Development
13.16 Quest Diagnostics
10.16.1 Quest Diagnostics Company Details
10.16.2 Quest Diagnostics Business Overview
10.16.3 Quest Diagnostics Hereditary Cancer Testing Introduction
10.16.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.16.5 Quest Diagnostics Recent Development
13.17 Pathway Genomics
10.17.1 Pathway Genomics Company Details
10.17.2 Pathway Genomics Business Overview
10.17.3 Pathway Genomics Hereditary Cancer Testing Introduction
10.17.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.17.5 Pathway Genomics Recent Development
13.18 Strand Life Sciences
10.18.1 Strand Life Sciences Company Details
10.18.2 Strand Life Sciences Business Overview
10.18.3 Strand Life Sciences Hereditary Cancer Testing Introduction
10.18.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020)
10.18.5 Strand Life Sciences Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hereditary Cancer Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Hereditary Cancer Testing Revenue
Table 3. Ranking of Global Top Hereditary Cancer Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of RNA Testing
Table 6. Key Players of DNA Testing
Table 7. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hereditary Cancer Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hereditary Cancer Testing Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hereditary Cancer Testing Market Share by Regions (2015-2020)
Table 11. Global Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hereditary Cancer Testing Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hereditary Cancer Testing Market Growth Strategy
Table 17. Main Points Interviewed from Key Hereditary Cancer Testing Players
Table 18. Global Hereditary Cancer Testing Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hereditary Cancer Testing Market Share by Players (2015-2020)
Table 20. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2019)
Table 21. Global Hereditary Cancer Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hereditary Cancer Testing Product Solution and Service
Table 24. Date of Enter into Hereditary Cancer Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hereditary Cancer Testing Market Size Share by Type (2015-2020)
Table 28. Global Hereditary Cancer Testing Revenue Market Share by Type (2021-2026)
Table 29. Global Hereditary Cancer Testing Market Size Share by Application (2015-2020)
Table 30. Global Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hereditary Cancer Testing Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hereditary Cancer Testing Market Share (2019-2020)
Table 34. North America Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 36. North America Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 38. Europe Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hereditary Cancer Testing Market Share (2019-2020)
Table 40. Europe Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 42. Europe Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 44. China Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hereditary Cancer Testing Market Share (2019-2020)
Table 46. China Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)
Table 47. China Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 48. China Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)
Table 49. China Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 50. Japan Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hereditary Cancer Testing Market Share (2019-2020)
Table 52. Japan Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 54. Japan Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hereditary Cancer Testing Market Share (2019-2020)
Table 58. Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 60. Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 62. India Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hereditary Cancer Testing Market Share (2019-2020)
Table 64. India Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)
Table 65. India Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 66. India Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)
Table 67. India Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hereditary Cancer Testing Market Share (2019-2020)
Table 70. Central & South America Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 72. Central & South America Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 74. Ambry Genetics (Konica Minota) Company Details
Table 75. Ambry Genetics (Konica Minota) Business Overview
Table 76. Ambry Genetics (Konica Minota) Product
Table 77. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 78. Ambry Genetics (Konica Minota) Recent Development
Table 79. Asper Biogene Company Details
Table 80. Asper Biogene Business Overview
Table 81. Asper Biogene Product
Table 82. Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 83. Asper Biogene Recent Development
Table 84. Natera Company Details
Table 85. Natera Business Overview
Table 86. Natera Product
Table 87. Natera Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 88. Natera Recent Development
Table 89. Caris Life Sciences Company Details
Table 90. Caris Life Sciences Business Overview
Table 91. Caris Life Sciences Product
Table 92. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 93. Caris Life Sciences Recent Development
Table 94. BioReference Laboratories (GeneDx) Company Details
Table 95. BioReference Laboratories (GeneDx) Business Overview
Table 96. BioReference Laboratories (GeneDx) Product
Table 97. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 98. BioReference Laboratories (GeneDx) Recent Development
Table 99. LabSolutions Company Details
Table 100. LabSolutions Business Overview
Table 101. LabSolutions Product
Table 102. LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 103. LabSolutions Recent Development
Table 104. Progenity，Inc Company Details
Table 105. Progenity，Inc Business Overview
Table 106. Progenity，Inc Product
Table 107. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 108. Progenity，Inc Recent Development
Table 109. ARUP Laboratories Business Overview
Table 110. ARUP Laboratories Product
Table 111. ARUP Laboratories Company Details
Table 112. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 113. ARUP Laboratories Recent Development
Table 114. NeoGenomics Company Details
Table 115. NeoGenomics Business Overview
Table 116. NeoGenomics Product
Table 117. NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 118. NeoGenomics Recent Development
Table 119. Blueprint Genetics Company Details
Table 120. Blueprint Genetics Business Overview
Table 121. Blueprint Genetics Product
Table 122. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 123. Blueprint Genetics Recent Development
Table 124. CellMax Life Company Details
Table 125. CellMax Life Business Overview
Table 126. CellMax Life Product
Table 127. CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 128. CellMax Life Recent Development
Table 129. Fulgent Genetics Company Details
Table 130. Fulgent Genetics Business Overview
Table 131. Fulgent Genetics Product
Table 132. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 133. Fulgent Genetics Recent Development
Table 134. Myriad Genetics Company Details
Table 135. Myriad Genetics Business Overview
Table 136. Myriad Genetics Product
Table 137. Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 138. Myriad Genetics Recent Development
Table 139. Myogenes Company Details
Table 140. Myogenes Business Overview
Table 141. Myogenes Product
Table 142. Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 143. Myogenes Recent Development
Table 144. LabCorp Company Details
Table 145. LabCorp Business Overview
Table 146. LabCorp Product
Table 147. LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 148. LabCorp Recent Development
Table 149. Quest Diagnostics Company Details
Table 150. Quest Diagnostics Business Overview
Table 151. Quest Diagnostics Product
Table 152. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 153. Quest Diagnostics Recent Development
Table 154. Pathway Genomics Company Details
Table 155. Pathway Genomics Business Overview
Table 156. Pathway Genomics Product
Table 157. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 158. Pathway Genomics Recent Development
Table 159. Strand Life Sciences Company Details
Table 160. Strand Life Sciences Business Overview
Table 161. Strand Life Sciences Product
Table 162. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)
Table 163. Strand Life Sciences Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2020 VS 2026
Figure 2. RNA Testing Features
Figure 3. DNA Testing Features
Figure 4. Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026
Figure 5. Breast Cancer Case Studies
Figure 6. Gastrointestinal Cancer Case Studies
Figure 7. Prostate Cancer Case Studies
Figure 8. Respiratory/Lung Cancer Case Studies
Figure 9. Other Cancers Case Studies
Figure 10. Hereditary Cancer Testing Report Years Considered
Figure 11. Global Hereditary Cancer Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Hereditary Cancer Testing Market Share by Regions: 2020 VS 2026
Figure 13. Global Hereditary Cancer Testing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Hereditary Cancer Testing Market Share by Players in 2019
Figure 16. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2019
Figure 18. North America Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
子宮がん診断検査の世界市場（～2026年） Uterus a female organ also referred as the womb is located in the lower abdomen. It supports in the fetal development until birth. In North America, the U.S. is expected to be the dominant market for uterine cancer diagnostic testing due to growing incidence of uterine cancer. Market Analysis and In…- がん検診/スクリーニングの世界市場（～2026年） Screening means checking your body for cancer before you have symptoms. In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer. Market Analysis and Insights: Global Cancer Testing/Screening Market The global Cancer Testing/Screening market…
- AFP検査の世界市場（～2026年） Alpha-fetoprotein (AFP) is a protein produced in the liver of a developing fetus. Globally AFP Testing market is expected to witness growth in the upcoming future due to increasing cancer awareness and growing number of geriatric population which are more susceptible to cancer. Market Analysis and I…
- 前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…
- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …